Displaying drugs 1801 - 1825 of 2780 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Gimeracil | 145.54 C5H4ClNO2 |  | A DPD inhibitor used as an adjunct to antineoplastic therapy to increase the systemic concentrations and therapeutic effectiveness of other antineoplastic agents. | Drugs that are Mainly Renally Excreted |
| Bemiparin | Not Available |  | An ultra-low molecular weight heparin (ultra-LMWH) used to prevent thromboembolism following surgery and extracorporeal clotting during dialysis. | Anticoagulants |
| Reviparin | Not Annotated |  | By the FDA, reviparin is indicated for the treatment of deep vein which may lead to pulmonary embolism in pediatric patients. It is also indicated for the long-term treatment of... | Anticoagulants |
| Parnaparin | Not Annotated |  | A low molecular weight heparin (LMWH) used to prevent blood clots, specifically deep vein thrombosis. | Anticoagulants |
| Certoparin | Not Annotated |  | A low molecular weight heparin (LMWH) used to prevent blood clots, specifically deep vein thrombosis. | Anticoagulants |
| Patiromer | Not Available |  | A non-absorbable potassium binding polymer indicated for the treatment of hyperkalemia. | Potassium Binder |
| Technetium Tc-99m tilmanocept | Not Available |  | A radiopharmaceutical diagnostic imaging agent indicated with or without scintigraphic imaging for lymphatic mapping and guiding sentinel lymph node biopsy. | Technetium (99Mtc) Compounds |
| Strontium ranelate | 513.49 C12H6N2O8SSr2 |  | A medication used for the management of severe osteoporosis in high-risk postmenopausal women and adult men. | Bone Density Conservation Agents / Strontium |
| Picosulfuric acid | 437.44 C18H15NO8S2 |  | A stimulant laxative used for cleansing of the colon as a preparation for colonoscopy in adults. | Laxatives |
| Phenylacetic acid | 136.1479 C8H8O2 |  | An agent used as an adjunct to treat acute hyperammonemia and associated encephalopathy in adult and pediatric patients with deficiencies in enzymes of the urea cycle. | Various Alimentary Tract and Metabolism Products |
| Ubidecarenone | 863.3435 C59H90O4 |  | A cofactor found in various dietary supplements. | Electron Transport Chain Complex Proteins / Ubiquinone / Vitamins |
| Eluxadoline | 569.662 C32H35N5O5 |  | A mixed mu-opioid receptor agonist used to treat irritable bowel syndrome with diarrhea. | Antipropulsives / Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome |
| Artesunate | 384.425 C19H28O8 |  | Artesunate is an artemesinin derivative indicated for the initial treatment of severe malaria. | Artemisinin and derivatives |
| Bismuth subcitrate potassium | 780.654 C12H8BiK5O14 |  | A colloid used for the treatment of peptic ulcer and gastro-esophageal reflux disease (GERD). | Neurotoxic agents |
| Sodium aurothiomalate | 390.07 C4H3AuNa2O4S |  | A disease-modifying antirheumatic drug (DMARD) indicated for the symptomatic treatment of arthritis. | Gold Preparations |
| Choline C 11 | 138.62 C5H14ClNO |  | Choline C11 is indicated for its use in positron emission tomography (PET) imaging in patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography or magnetic resonance imaging.[FDA... | Drugs that are Mainly Renally Excreted |
| Activated charcoal | 12.011 C |  | A gastric decontamination agent used in emergency clinical settings as a antidote to treat poisonings following excessive oral ingestion of certain medications or poisons. | Charcoal Preparations |
| Lumacaftor | 452.414 C24H18F2N2O5 |  | A protein chaperone used in combination with ivacaftor for the treatment of cystic fibrosis in patients who are homozygous for the F508del mutation in the CFTR gene. | Amines / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inducers (strong) / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strong) / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Dioxoles / Heterocyclic Compounds, Fused-Ring / P-glycoprotein inducers / P-glycoprotein inhibitors / Pyridines |
| Magnesium trisilicate | 260.857 Mg2O8Si3 |  | An antacid used for the symptomatic treatment of peptic ulcers. | Antacids / Laxatives |
| Molsidomine | 242.235 C9H14N4O4 |  | A long-acting vasodilator used to treat angina pectoris, including in association with left heart failure and acute myocardial infarction. | Morpholines / Nitric Oxide Donors / Sydnones / Vasodilating Agents |
| Polyethylene glycol | Not Available |  | A laxative used to treat constipation and used for bowel preparation before colonoscopies and other procedures. | Electrolytes / Ethylene Glycols / Excipients / Laxatives / Osmotic Laxatives / Polyethylene Glycols / Polymers / Solvents / Surface-Active Agents |
| Rolapitant | 500.485 C25H26F6N2O2 |  | A neurokinin-1 (NK-1) receptor antagonist used in combination with other antiemetics for the prevention of delayed nausea and vomiting associated with emetogenic chemotherapy. | Neurokinin-1 Receptor Antagonists / Substance P/Neurokinin-1 Receptor Antagonist |
| Sacubitril | 411.498 C24H29NO5 |  | A neprilysin inhibitor used in combination with valsartan as an adjunct to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction. | Neprilysin Inhibitor / Neprilysin, antagonists & inhibitors |
| Iodide I-131 | 130.9067 I |  | A radioisotopic agent used for the treatment of hyperthyroidism and thyroid carcinomas that take up iodine. | Iodine (131I) Compounds |
| Ombitasvir | 894.127 C50H67N7O8 |  | A direct acting antiviral agent used in combination with other antiviral agents for the treatment of Hepatitis C Virus (HCV) infections. | Antivirals for treatment of HCV infections |
Displaying drugs 1801 - 1825 of 2780 in total